Pharmafile Logo
Pharmafocus logo
Advanced Search
merck_entrance

FDA shutters MSD’s Keytruda combination trials in myeloma

July 6, 2017
Medical Communications, Research and Development MSD, immunotherapy, keytruda, pd-1

Following on from the news last month that enrolment for Keytruda being used alongside Celgene’s Imnovid and Revlimid would have …

News
ob_logo

Oxford BioMedica in $100 million manufacturing deal with Novartis

July 6, 2017
Manufacturing and Production, Sales and Marketing Novartis, Oxford BioMedica

Oxford BioMedica has announced that it has signed a contract with Novartis to supply the company with materials in a …

News
gilead-sciences

Gilead to launch injunction against Mylan and Actavis over HIV generics in Ireland

July 6, 2017
Sales and Marketing Actavis, Gilead, HIV, Mylan, Truvada

Gilead is expected to launch injunctive action against rivals Mylan and Actavis over the allegation that they are planning to …

News
tau_tangle

Atomic structure of tau revealed opening up new Alzheimer’s targets

July 6, 2017
Research and Development Alzheimer's disease, dementia, tau protein, tau tangle

It is a research breakthrough that has been touted as the biggest development in Alzheimer’s disease research for a quarter …

News
heart_money

Heart failure market to quadruple in ten years to $16 billion

July 6, 2017
Sales and Marketing GlobalData, Novartis, heart failure

New research from intelligence firm GlobalData has indicated that the market for heart failure drugs is forecast to expand by …

News
cancer_cells

Breakthrough in personalised medicine as cancer vaccine shows results

July 6, 2017
Research and Development Precision Medicine, personalised medicine, precision oncology

The old adage that everyone is unique holds a lot of water when it comes to cancer treatment. Research has …

News

Merck Foundation created and CEO set in place

July 5, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck Foundation, Merck KGaA

Merck KGaA announced that is has created the Merck Foundation and has appointed Rasha Kelej as its CEO. The role …

Appointment
eu_and_fda

EMA and FDA harmonise over development of Gaucher drugs

July 5, 2017
Medical Communications, Research and Development, Sales and Marketing EMA, FDA, Gaucher disease

The EMA and the FDA have announced that they have developed a joint proposal to promote more efficient means of …

News

NICE agrees approval deal for ultra-rare juvenile bone disease

July 5, 2017
Research and Development, Sales and Marketing Alexion, NICE, Strensiq

NICE has announced that it has decided to approve Alexion Pharma’s Strensiq (asfotase alfa) for the treatment of ultra-rare disease …

News
8384110298_da510e0347_c

Google’s DeepMind app deal with NHS brought into question

July 5, 2017
Medical Communications, Research and Development Alphabet, DeepMind, NHS, google

DeepMind’s deal with the NHS to develop an app that is able to detect possible kidney damage involved 1.6 million …

News
shutterstock_159488225

Tumour genome mapping could lead to improved outcomes, research finds

July 5, 2017
Research and Development Cancer, Hi-C

A research team at the Babraham Institute in Cambridge, UK has revealed a new method to detect and monitor large-scale …

News
new_wave_logo_cmyk

Gain insight into what your peers are doing

July 5, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, wave

When they first came along, webinars were the equivalent of an outside broadcast unit, lots of hardware, dedicated studios and …

Feature
shutterstock_38078521

Researchers boost existing antibiotic to tackle drug resistance

July 4, 2017
Research and Development University of Lincoln, antibiotic resistance

The growing issue of antibiotic resistance is finding itself increasingly central in pharma’s priorities, though many still argue that the …

News

Stada CEO and CFO tumble in takeover turmoil

July 4, 2017
Sales and Marketing Bain capital, Cinven, Stada

Stada, the German generic drugs manufacturer, saw its two most senior executives leave the company for ‘personal reasons’. Matthias Wiedenfels, …

News
sunpharma

Sun Pharma signs $55m manufacturing deal for investigational psoriasis drug

July 4, 2017
Manufacturing and Production Samsung BioLogics, Sun Pharma

India’s biggest pharma firm has signed a $55 million long-term manufacturing deal with Korea’s Samsung BioLogics for Tildrakizumab, an investigational …

News

Johnson & Johnson face major lawsuit over vaginal mesh

July 4, 2017
Manufacturing and Production, Sales and Marketing J&J, JJ, Johnson & Johnson, lawsuit, vaginal mesh

Johnson & Johnson will face a lawsuit after 700 Australian women launched a class action suit over the failures of …

News
shutterstock_146497481

Top CMO pushes for routine genome screening on NHS

July 4, 2017
Manufacturing and Production, Research and Development NHS, genome sequencing

England’s top Chief Medical Officer has called for routine DNA testing to become standard on the NHS in a bid …

News
brexit_flag_0

Ministers move to clarify drug regulation Post-Brexit

July 4, 2017
Manufacturing and Production, Medical Communications EMA, Jeremy Hunt, MHRA, NHS, NICE

Jeremy Hunt, Health Secretary, and Greg Clark, Business Secretary, have made a bold move to suggest that the UK will …

News
astrazeneca_building_white

AstraZeneca generates $600 million from just two drug sales

July 3, 2017
Manufacturing and Production, Sales and Marketing AstraZeneca, Seloken, Zomig

AstraZeneca is expected to generate almost $600 million from just two drug sales: Zoming, a migraine therapy, and Seloken, a …

News

Forging a path forward in neurological disorders

July 3, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing neurological disorders

The development of innovative treatments for neurological disorders such as dementia has stagnated over the past decade despite being an …

Feature
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026